Clinical Trials Browser

Observational × Neoplasm Metastasis × Cetuximab × Clear all

NCT01082315 2014-08-29

A Korean Post-marketing Surveillance Study on Erbitux® in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-containing Treatment

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01074333 2014-06-17

An Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing Treatment

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms